Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study
Brain · 2024
DOI: 10.1093/brain/awae271 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Brain, 2024. Verfasst von Andrea Calcagno und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, 10149 Turin, Italy. Hauptthemen laut MEDLINE: HIV Infections, Biomarkers, Neurofilament Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Ricerca Finalizzata di Rete, Viiv Healthcare.
Abstract (Originalsprache)
It is debated whether CNS involvement begins during acute human immunodeficiency virus (HIV) infection in persons without meningitis/encephalitis and whether specific antiretroviral drugs or combinations would be beneficial. Neurologically asymptomatic participants enrolled in a randomized and controlled study comparing three combination antiretroviral regimens (tenofovir alafenamide/emtricitabine plus dolutegravir; darunavir; or both) during primary HIV infection were enrolled. Serum and CSF were collected at baseline and at 12 and 48 (serum only) weeks after treatment initiation. Single molecule array was used to measure neurofilament light chain (NFL), total tau protein (Tau), brain-derived neurotrophic factor, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase. We assessed the longitudinal change in biomarkers over time, in addition to the change in the prevalence of serum NFL concentrations above previously published age-adjusted cut-offs (7 pg/ml if 5–18 years, 10 pg/ml if 18–51 years, 15 pg/ml if 51–61 years, 20 pg/ml if 61–70 years and 35 pg/ml if >70 years). Serum was available from 47 participants at all time points, and CSF was available from 13 participants at baseline and 7 at Week 12. We observed a significant direct serum-to-CSF correlation for NFL (ρ = 0.692, P = 0.009), GFAP (ρ = 0.659, P = 0.014) and brain-derived neurotrophic factor (ρ = 0.587, P = 0.045). Serum (ρ = 0.560, P = 0.046) and CSF NFL (ρ = 0.582, P = 0.037) concentrations were directly associated with CSF HIV RNA levels. We observed a significant decrease over time in serum NFL (P = 0.006) and GFAP (P = 0.006) but not in the other biomarkers. No significant difference was observed among the treatment arms. At baseline, serum and CSF age-adjusted NFL levels were above age-adjusted cut-offs in 23 (48.9%) and four participants (30.8%), respectively; considering serum NFL, this proportion was lower at Weeks 12 (31.9%, P = 0.057) and 48 (27.7%, P = 0.13). A relevant proportion of neurologically asymptomatic participants had abnormal CSF and serum NFL levels during primary HIV infection. NFL and GFAP decreased in serum following combination antiretroviral therapy without significant differences among the treatment arms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.
- Laboratory of Clinical Pharmacology and Pharmacogenetics, University of Turin, 10149 Turin, Italy.
- Infectious Diseases Unit, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
- Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, 20142 Milan, Italy.
- School of Medicine and Surgery, University of Milan, 20122 Milan, Italy.
- Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4 School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
ORCID-Profile: Andrea Calcagno, Jessica Cusato, Mattia Trunfio, Stefano Rusconi, Diego Ripamonti, Silvia Nozza
Förderung
- Italian Ministry of Health
- Ricerca Finalizzata di Rete
- Viiv Healthcare
Zitieren
APA
Calcagno, A., Cusato, J., Cinque, P., Marchetti, G., Bernasconi, D., Trunfio, M., Bruzzesi, E., Rusconi, S., Gabrieli, A., Muscatello, A., Antinori, A., Ripamonti, D., Gulminetti, R., Antonucci, M., & Nozza, S. (2024). Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. Brain. https://doi.org/10.1093/brain/awae271
Vancouver
Calcagno A, Cusato J, Cinque P, Marchetti G, Bernasconi D, Trunfio M, et al. Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. Brain. 2024. doi:10.1093/brain/awae271
BibTeX
@article{Calcagno2024,
author = {Calcagno, Andrea and Cusato, Jessica and Cinque, Paola and Marchetti, Giulia and Bernasconi, Davide and Trunfio, Mattia and Bruzzesi, Elena and Rusconi, Stefano and Gabrieli, Arianna and Muscatello, Antonio and Antinori, Andrea and Ripamonti, Diego and Gulminetti, Roberto and Antonucci, Miriam and Nozza, Silvia},
title = {Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae271}
}
EUVIMED